Keyword: Hepatitis

Markets & Companies

Vaccine Research – an Ambitious and Important Venture

20.04.2020 - The worldwide spread of the corona virus shows once again that despite all technological progress, humanity is still exposed to health risks. The biotech and pharmaceutical...

News

Dynavax Wins FDA Approval for Hepatitis B Vaccine

24.11.2017 - US immunology company Dynavax has finally secured approval from the US Food and Drug Administration (FDA) for its hepatitis B vaccine. Heplisav-B is the first new vaccine to be...

News

MRC Licenses Hepatitis C Antibody to China

21.03.2017 - UK medical research charity MRC Technology has licensed an antibody to Newsummit Biopharma, a leading Chinese drug developer, in an effort to create a novel therapeutic for...

News

Gilead Sciences Faces Another Hepatitis C Lawsuit

05.09.2016 - Gilead Sciences is once again preparing to defend itself against a challenge to its hepatitis C intellectual property. The latest lawsuit comes from the University of Minnesota...

News

FDA Approves Pill for all Hepatitis C Forms

04.07.2016 - The US Food and Drug Administration has approved Gilead Sciences’ combination pill Epclusa, the first to treat all major forms of hepatitis C. This is the latest in a series of...

Markets & Companies

Leaving the Patent Cliff Behind

07.10.2015 - The pharmaceutical industry is entering a period of sustained growth. Prescription drug sales are set to advance at almost 5% a year until 2020, while worldwide prescription drug...